Authors suggest ISCHEMIA-EXTEND’s finding of noncardiac mortality excess risk observed following revascularization ‘likely due to a statistical Type I error’
There is no significant difference in non-cardiac mortality between revascularization plus medical therapy (MT) compared with MT alone in patients with chronic coronary syndrome (CCS), according to a new meta-analysis of existing trial data.